【レポートの概要(一部)】
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview
Orphan medicines legislation
Orphan medicines centralized procedure in US/EU
Product registration process for orphan drugs in Japan
Orphan drug designations and approvals
Annual cost of orphan drugs
R&D costs for orphan and non-orphan drugs
PART 06: Pipeline snapshot
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by product
Global biologic orphan drugs market
Global non-biologic orphan drugs market
PART 09: Geographical segmentation
Orphan drugs market in Americas
Orphan drugs market in EMEA
Orphan drugs market in APAC
PART 10: Market drivers
Shorter development timelines
Assistance from regulatory bodies
Incentives for developing orphan drugs
High return on investment
Exemption from pricing constraints
PART 11: Impact of drivers
PART 12: Market challenges
High cost of drug development
Decreased investment in marketing
Complications in conducting clinical trials
Unknown pathophysiology
Adverse policies of FDA
PART 13: Impact of drivers and challenges
PART 14: Market trends
Increased focus on biological drugs
Growing awareness of orphan drugs
Channel marketing strategy
Expansion of business
Entry into untapped market
PART 15: Vendor landscape
Competitive scenario
Major vendors 2014
Worldwide orphan drug sales revenue: Top 17 companies 2013
Top 10 orphan drugs in US 2014
Other prominent vendors
PART 16: Key vendor analysis
BMS
Celgene
Novartis
Pfizer
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: History of orphan medicines legislation
Exhibit 03: Incentives provided by US regulation
Exhibit 04: Incentives provided by Japanese regulation
Exhibit 05: Incentives provided by EU regulation
Exhibit 06: Incentives provided by Australian regulation
Exhibit 07: Incentives provided by South Korean regulation
Exhibit 08: Incentives provided by Singapore regulation
Exhibit 09: Orphan drug regulatory process in EU/US
Exhibit 10: Orphan drug registration process in Japan
Exhibit 11: Orphan drug development and regulatory challenges
Exhibit 12: Orphan drug designations and approvals in US 2000-2014
Exhibit 13: Number of novel orphan molecular entities launched in US 2004-2013
Exhibit 14: Novel orphan molecular entities launched in US 2013
Exhibit 15: Number of orphan drug designations and approvals in Japan 2000-2012
Exhibit 16: Number of orphan medicinal products launched in Europe 2002-2014
Exhibit 17: Top orphan drug designation indications in EU 2014
Exhibit 18: Approved and designated orphan pharmaceutical products in US, EU, Japan, and Australia
Exhibit 19: Cumulative orphan designations in US, EU, and Japan per year 2000-2013
Exhibit 20: Source: Technavio, 2015Orphan drug designations by therapy areas 2013
Exhibit 21: Average annual cost of orphan drugs per patient in US 2010-2014 ($)
Exhibit 22: Annual cost of several orphan drugs
Exhibit 23: Cost comparison of branded orphan drugs versus generic versions 2013 ($)
Exhibit 24: Orphan drug expenditure by therapeutic class 2007-2013
Exhibit 25: R&D cost for Phase III trial for orphan and non-orphan drugs 2013 and 2014 ($ billions)
Exhibit 26: The worldwide top late-stage and filed orphan drugs are given below:
Exhibit 27: Global orphan drugs market ($ billions)
Exhibit 28: Five forces analysis
Exhibit 29: Global orphan drugs market by product
Exhibit 30: Global orphan drugs market by product 2014
Exhibit 31: Global biologic orphan drugs market 2014-2019 ($ billions)
Exhibit 32: Global non-biologic orphan drugs market 2014-2019 ($ billions)
Exhibit 33: Global orphan drugs market by geographical segmentation 2014
Exhibit 34: Orphan drugs market in Americas 2014-2019 ($ billions)
Exhibit 35: Orphan drugs market in EMEA 2014-2019 ($ billions)
Exhibit 36: Orphan drugs market in APAC 2014-2019 ($ billions)
Exhibit 37: )Global orphan drugs market by geographical segmentation 2014-2019 ($ billions)
Exhibit 38: Drivers of global orphan drugs market
Exhibit 39: FDA filed to approved time: orphan versus non-orphan drugs (median time months)
Exhibit 40: Phase III trial length orphan versus non-orphan drugs (median length years)
Exhibit 41: Impact of drivers
Exhibit 42: Challenges in global orphan drugs market
Exhibit 43: Impact of key drivers and challenges
Exhibit 44: Trends in global orphan drugs market
Exhibit 45: BMS: Key takeaways
Exhibit 46: Celgene: Global year-over-year growth and revenue of Vidaza 2012-2014 ($ millions)
Exhibit 47: Celgene: Global year-over-year growth and revenue of Revlimid 2012-2014 ($ billions)
Exhibit 48: Celgene: Key takeaways
Exhibit 49: Novartis: Key takeaways
Exhibit 50: Pfizer: Year-on-year growth rate and revenue of Inlyta 2012-2014 ($ millions)
Exhibit 51: Pfizer: Key takeaways
Exhibit 52: Global year-over-year growth and revenue of Rituxan/MabThera 2010-2014 ($ billions)
Exhibit 53: Avastin: Global revenue and year-over-year growth 2010-2014 ($ billions)
Exhibit 54: Roche: Key takeaways
Exhibit 55: Worldwide orphan drug sales 2007-2013 ($ billions)
Exhibit 56: BMS: Business segmentation by revenue 2014
Exhibit 57: BMS: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 58: BMS: Geographical segmentation by revenue 2014
Exhibit 59: Celgene: Product segmentation by revenue 2014
Exhibit 60: Celgene: Product segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 61: Celgene: Geographical segmentation by revenue 2014
Exhibit 62: Roche: Business segmentation by revenue 2014
Exhibit 63: Roche: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 64: Roche: Geographical segmentation by revenue 2014
Exhibit 65: Novartis: Business segmentation by revenue 2014
Exhibit 66: Novartis: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 67: Novartis: Geographical segmentation by revenue 2014
Exhibit 68: Pfizer: Business segmentation by revenue 2014
Exhibit 69: Pfizer: Business segmentation by revenue 2014 (%)
Exhibit 70: Pfizer: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル:希少疾病用医薬品(OD)の世界市場2015-2019■ 英文:Orphan Drugs Market 2015-2019
■ 発行日:2015年11月11日
■ 調査会社:Technavio
■ 商品コード:IRTNTR7493
■ 調査対象地域:グローバル
- 世界の上位10か国におけるアウトバウンドツーリズム市場:観光客数、支出動向Summary Top 10 Outbound Tourism Markets, Trips and Spending per Country To 2018 provides detailed information on the top 10 outbound tourism markets globally. This report analyzes market data and provides a better understanding of tourism flows and tourist expenditure. Key Findings - Mexico is the leading tourist destination for Americans, accounting for 30.4% of total international departures in …
- 緑茶の世界市場2015-2019About Green Tea Green tea is made using the leaves of the plant Camellia sinensis. The leaves undergo less oxidation during processing. It is a rapidly growing market because of increasing awareness about its medical advantages. Extracts of green tea are used in beverages, dietary supplements, dental care items, cosmetics, and medicines. Technavio's analysts forecast the global green tea market to …
- タイトガスの世界市場:用途別(発電、工業、住宅、商業、輸送)、地域別予測Global Tight Gas Market to reach USD XXX billion by 2025. Global Tight Gas Market valued approximately USD XXX billion in 2016 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2017-2025. Increasing need for Non-conventional gas, and the use of Tight Gas in Industrial, Residential, Commercial, Power generation, Transportation, increasing price of oil, rece …
- 世界の自動車タイヤ産業研究:Study on Global Automotive Tyre Industry – 2014This report provides an insight into the Study on Global Automotive Tyre Industry current scenario, structure and practices. In depth market scenario includes; - Global Automotive Tyre Market - Regional Tyre Market - Africa, Middle East, South East Asia, Central Asia - Off-the-road Tyre Market Market structure details the followings - Production of vehicles - OE Tyre Sales - Replacement Tyre Sales …
- モジュラー変電所の世界市場動向及び予測Modular substation is cost effective, compact and a smart replacement for the traditional substation with many technical and commercial benefits. It is a ready to install product and can reduce the spatial requirement up to 30%. Reduced maintenance, high level of safety from cyber-attacks, and real-time monitoring are some of the benefits that distinguish modular substation from a traditional subs …
- 電気・電子産業におけるDM(デジタルマニュファクチャリング)の世界市場2017-2021About Digital Manufacturing DM is one of the emerging PLM solutions in the world. The adoption of DM allows the engineers to create a virtual environment of the manufacturing process starting from product definition to manufacturing. It creates digital models of tools, assembly lines, work centers, plant layout, and resources. DM provides simulation, visualization, analytics, and collaboration to …
- BP p.l.c.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013BP p.l.c. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary BP p.l.c. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational dat …
- IoTクラウドプラットフォームの世界市場予測(~2021年)MarketsandMarkets forecasts the Internet of Things (IoT) cloud platform market size to grow from USD 1.88 Billion in 2016 to USD 7.15 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 30.6%. Increasing adoption of intelligent/smart devices and cost-effective & easily deployable cloud data storage are some of the key factors driving the market. Other driving forces include the growing nee …
- 世界の板ガラス市場2014-2024The world market for flat glass will reach $83bn in 2014. As the demand for value-added glass in the Building and Construction, Automotive and Solar Energy industry rises; new technological developments which have increased the functionality of glass have created new and increasing applications of flat glass, thus, driving the market. Despite the slowdown of mature economies such as North America …
- ブラジルの3PL(サードパーティー・ロジスティクス)市場About 3PL in Brazil 3PL is a business process where companies outsource their logistics and distribution functions to a service provider that specializes in handling logistics activities such as transportation, warehousing, and freight and forwarding. 3PL providers have expertise in managing and customizing the supply chain as per the needs of the customers. They also provide strategic and operati …
- ライフスタイル・ドラッグ(生活改善薬)の世界市場2017-2021About Lifestyle Drugs MarketLifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity. Technavio’s analysts forecast the global lifestyle drugs market to grow at a CAGR of 2.87% during the period 2017-2021. [Covered in this report] The report covers the present scenari …
- 流量計校正の世界市場2018-2022About Flowmeters A flowmeter measures the rate at which a fluid or gas passes through it. Calibration process in a flowmeter assures that measurements match the specified and reference values. Technavio’s analysts forecast the Global Flowmeter Calibration Market to grow at a CAGR of 6.19% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth pros …
- 医療機器の外注の世界市場分析:用途別(クラスI、クラスII、クラスIII)、サービス別(規制コンサルティング、製品設計と開発、製品テスト、製品実装、製品アップグレード、製品メンテナンス)、セグメント予測、2014-2025The global medical device outsourcing market is expected to reach USD 88.2 billion by 2025, according to a new report by Grand View Research, Inc. Rising price competition and rising need for reduction of production cost are the most impact rendering driver of the medical device outsourcing market. Sharp cutbacks in the public spending in major EU regions and the U.S., is the major issue currently …
- 非侵襲的出生前検査の世界市場分析:妊娠期間別(0-12週、13-24週、25-36週)、妊娠リスクレベル別、(高リスク – 平均リスク、低リスク)、地域別(アメリカ、イギリス、ドイツ、日本、中国、ブラジル)、セグメント予測、2014-2025The global non-invasive prenatal testing market is anticipated to reach USD 5.5 billion by 2025, according to a new report by Grand View Research, Inc. Evolution of prenatal testing in the form of noninvasive tests that can serve as an intermediate step between serum screening and invasive diagnostic testing to determine the likelihood of fetal abnormality is expected to drive growth in the reprod …
- プリンターのグローバル市場動向Taiyou Research analyzes the global market for printers in its latest research report. The report takes a look at the global market for laser printers, color inkjet printers, monochrome laser printers and color laser printers. The report analyzes the printer market in Asia Pacific, Europe (particularly Western Europe) and the United States. Each region and segment is analyzed through average sales …